tiprankstipranks
Dogwood Therapeutics (DWTX)
NASDAQ:DWTX
US Market
DWTX
Dogwood Therapeutics
RESEARCH TOOLSreports

Dogwood Therapeutics (DWTX) Financial Statements

259 Followers

Dogwood Therapeutics Financial Overview

Dogwood Therapeutics's market cap is currently $70.48M. The company's EPS TTM is $-0.26; its P/E ratio is -3.99; Dogwood Therapeutics is scheduled to report earnings on April 6, 2026, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -12.18K$ 0.00$ 0.00$ 0.00
Operating Income$ -27.97M$ -12.23M$ -5.45M$ -12.32M$ -15.64M
EBITDA$ -27.97M$ -12.25M$ -5.45M$ -12.32M$ -15.64M
Net Income$ -34.26M$ -12.35M$ -5.30M$ -12.25M$ -15.96M
Balance Sheet
Cash & Short-Term Investments$ 6.52M$ 14.85M$ 3.32M$ 7.03M$ 14.01M
Total Assets$ 90.17M$ 94.31M$ 4.17M$ 8.37M$ 15.78M
Total Debt$ 162.60K$ 15.59M$ 0.00$ 0.00$ 0.00
Net Debt$ -6.36M$ 737.71K$ -3.32M$ -7.03M$ -14.01M
Total Liabilities$ 15.27M$ 30.03M$ 358.55K$ 1.04M$ 1.28M
Stockholders' Equity$ 74.90M$ 64.28M$ 3.81M$ 7.33M$ 14.50M
Cash Flow
Free Cash Flow$ -15.62M$ -8.79M$ -4.87M$ -11.47M$ -15.69M
Operating Cash Flow$ -15.62M$ -8.79M$ -4.87M$ -11.47M$ -15.69M
Investing Cash Flow$ 0.00$ 3.76M$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 7.28M$ 16.70M$ 1.16M$ 4.49M$ -97.60K
Currency in USD

Dogwood Therapeutics Earnings and Revenue History

Income Statement >

Dogwood Therapeutics Debt to Assets

Balance Sheet >

Dogwood Therapeutics Cash Flow

Cash Flow >

Dogwood Therapeutics Forecast EPS vs Actual EPS

Earnings >